Existing COVID-19 vaccines are likely to be less effective against the emerging Omicron variant, Moderna CEO Stéphane Bancel predicted on Tuesday. "There is no world, I think, where [the effectiveness] is the same level ... we had with [the] Delta [variant]," he told the Financial ...
VACCINE effectivenessThe creation of a vaccine against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has received top focus worldwide. The majority of the COVID-19 vaccine candidates created is given Intramuscularly (IM). Intranasal (IN) vacci...
56The CDC reported that vaccine effectiveness decreased in selected medically compromised groups, resulting in higher risks of COVID-19 breakthrough infections
Current COVID-19 vaccines present the spike protein in very different ways to the immune system, and two main categories have to be discerned. The first category consists of mRNA and adenoviral vector vaccines (herein referred to as genetic vaccines, sections: “Genetic vaccines—general, “mRNA...
The recent emergence of different variants of SARS-CoV-2 is becoming a new threat for the world and a challenge for scientists to introduce the most influential vaccine against COVID-19. The possibility of natural and vaccine-induced immunity in variants finds it necessary to establish next-...
Treatment of the novel Coronavirus Disease 2019 (COVID-19) remains a complicated challenge, especially among patients with severe disease. In recent studie
This effect has included the adverse outcomes in patients with cancer who develop COVID-19, the impact of the COVID-19 pandemic on the delivery of cancer care, and the severe disruption to cancer research. However, patients with cancer are a heterogeneous population, and recent studies have ...
A chimpanzee adenovirus vector (ChAdOx1) was one of the first COVID-19 vaccines approved for use in humans and was administered to millions globally [66]. CEPI has supported the development of a ChAdOx1 vectored LASV vaccine that expresses LASV GPC (ChAdOx1-LASV-GPC) and its movement ...
The effective management of the coronavirus disease 2019 (COVID-19) pandemic depends on the bedrock of rapid and accurate testing to enable promptness in quarantining, contact tracing, epidemiologic characterization, evaluating vaccine response, and stra
"Over the past two years, the number of reported measles cases in Europe have been low, probably due to COVID-19 control measures rather than reaching the 95% immunization target for measles vaccination. However, our analysis suggests that even if routine two-dose measles vaccination reaches 95...